ClinicalTrials.Veeva

Menu

Register of Patients With Prader-Willi Syndrome

T

Toulouse University Hospital

Status

Enrolling

Conditions

Prader-Willi Syndrome

Treatments

Other: Data collection

Study type

Observational

Funder types

Other

Identifiers

NCT02829684
07 315 03

Details and patient eligibility

About

Prader-Willi Syndrome (PWS) is a rare syndrome with a prevalence of 15 to 20 000 at birth. PWS represents a large fraction of mental retardation syndromes due to a genetic cause and the most frequent cause of genetic obesity. The majority of the patients are seen by paediatricians. This syndrome is responsible for severe physical, psychological and social impairments.

The diversity and the severity of the manifestations of this disease explain the requirement of multidisciplinary care which deserve specific evaluation. Today the follow-up and management of a great proportion of these patients are greatly insufficient if not absent.

Teams strongly lack information on the natural history of this severe disease and on the factors involved in its evolution and the outcome of these patients throughout life. The present project is to implement a register in the whole country for children and adult patients

Enrollment

500 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all subjects with a Prader-Willi Syndrome

Exclusion criteria

Trial contacts and locations

1

Loading...

Central trial contact

MOLINAS Catherine, CRA; TAUBER Maité, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems